Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
MacroGenics
Scientific Title
A Phase 1, First-in-Human, Open-Label, Dose Escalation Study of MGD013, A Bispecific DART Protein Binding PD-1 and LAG-3 in Patients With Unresectable or Metastatic Neoplasms